Rodman & Renshaw Starts Eyegate Pharmaceuticals (EYEG) at Buy
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.31 -0.72%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Rodman & Renshaw initiated coverage on Eyegate Pharmaceuticals (NASDAQ: EYEG) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Eyegate Pharmaceuticals click here. For more ratings news on Eyegate Pharmaceuticals click here.
Shares of Eyegate Pharmaceuticals closed at $1.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
- Raymond James Starts Bank OZK (OZK) at Market Perform
- Alliance Global Partners Starts Strategy (MSTR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
